Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.vaccine.2016.02.063
Title: Memory T Cell Responses Targeting the SARS Coronavirus Persist up to 11 Years Post-Infection
Authors: Ng, Oi Wing 
Chia, Adeline
Tan, Anthony T
Jadi, Ramesh S.
Leong, Hoe Nam
Bertoletti, Antonio 
Tan, Yee Joo 
Keywords: Epitope
Immunity
SARS-CoV
T cell
Issue Date: 12-Apr-2016
Publisher: Elsevier Ltd
Citation: Ng, Oi Wing, Chia, Adeline, Tan, Anthony T, Jadi, Ramesh S., Leong, Hoe Nam, Bertoletti, Antonio, Tan, Yee Joo (2016-04-12). Memory T Cell Responses Targeting the SARS Coronavirus Persist up to 11 Years Post-Infection. Vaccine 34 (17) : 2008–2014. ScholarBank@NUS Repository. https://doi.org/10.1016/j.vaccine.2016.02.063
Abstract: Severe acute respiratory syndrome (SARS) is a highly contagious infectious disease which first emerged in late 2002, caused by a then novel human coronavirus, SARS coronavirus (SARS-CoV). The virus is believed to have originated from bats and transmitted to human through intermediate animals such as civet cats. The re-emergence of SARS-CoV remains a valid concern due to the continual persistence of zoonotic SARS-CoVs and SARS-like CoVs (SL-CoVs) in bat reservoirs. In this study, the screening for the presence of SARS-specific T cells in a cohort of three SARS-recovered individuals at 9 and 11 years post-infection was carried out, and all memory T cell responses detected target the SARS-CoV structural proteins. Two CD8(+) T cell responses targeting the SARS-CoV membrane (M) and nucleocapsid (N) proteins were characterized by determining their HLA restriction and minimal T cell epitope regions. Furthermore, these responses were found to persist up to 11 years post-infection. An absence of cross-reactivity of these CD8(+) T cell responses against the newly-emerged Middle East respiratory syndrome coronavirus (MERS-CoV) was also demonstrated. The knowledge of the persistence of SARS-specific celullar immunity targeting the viral structural proteins in SARS-recovered individuals is important in the design and development of SARS vaccines, which are currently unavailable.
Source Title: Vaccine
URI: http://scholarbank.nus.edu.sg/handle/10635/123749
ISSN: 0264410X
DOI: 10.1016/j.vaccine.2016.02.063
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
2016-Memory_cell_responses_targeting_SARS-preprint.pdf1.63 MBAdobe PDF

OPEN

Pre-printView/Download

SCOPUSTM   
Citations

5
checked on Dec 5, 2019

WEB OF SCIENCETM
Citations

6
checked on Dec 5, 2019

Page view(s)

132
checked on Nov 29, 2019

Download(s)

25
checked on Nov 29, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.